We are live on
!
Find out more
MIM
Meros Investment Management Portfolio holdings
AUM
$231M
1-Year Est. Return
35.94%
This Fund
S&P 500
This Quarter
Est. Return
-6.75%
1 Year Est. Return
+35.94%
3 Year Est. Return
+52.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97M
AUM Growth
-$10.8M
(-10%)
Cap. Flow
+$1.23M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
44.29%
Holding
41
New
6
Increased
13
Reduced
19
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
i3 Verticals
IIIV
|
+$2.7M |
| 2 |
Orion
OEC
|
+$2.63M |
| 3 |
BRY
Berry Corp
BRY
|
+$2.09M |
| 4 |
HSKA
Heska Corp
HSKA
|
+$1.69M |
| 5 |
Ranpak Holdings
PACK
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$6.53M |
| 2 |
HIL
Hill International, Inc. Common Stock
HIL
|
+$2.6M |
| 3 |
VNTR
Venator Materials PLC
VNTR
|
+$2.31M |
| 4 |
BioLife Solutions
BLFS
|
+$1.19M |
| 5 |
Photronics
PLAB
|
+$679K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Industrials | 20.75% |
| 3 | Healthcare | 16.93% |
| 4 | Consumer Discretionary | 13.71% |
| 5 | Materials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Harvard Bioscience
HBIO
$28.8M
| $1.89M | 1.94% |
73,643
+11,445
| +18% | +$379K |
|
27
Red Violet
RDVT
$926M
| $1.83M | 1.89% |
105,896
+19,825
| +23% | +$395K |
|
28
QCR Holdings
QCRH
$1.7B
| $1.79M | 1.84% |
35,075
-62
| -0.2% | -$3.47K |
|
29
Cerence
CRNC
$403M
| $1.46M | 1.51% |
92,787
-146
| -0.2% | -$3.28K |
|
|
HSKA
30
DELISTED
Heska Corp
HSKA
| $1.39M | 1.43% |
+19,069
| New | +$1.69M |
|
|
TEAD
31
Teads Holding Co
TEAD
$64.5M
| $1.37M | 1.42% |
376,534
+89,478
| +31% | +$435K |
|
32
The ONE Group
STKS
$56.5M
| $1.02M | 1.05% |
+152,983
| New | +$1.18M |
|
|
NOTV
33
DELISTED
Inotiv
NOTV
| $847K | 0.87% |
+50,286
| New | +$923K |
|
|
34
Ranpak Holdings
PACK
$446M
| $829K | 0.85% |
+242,295
| New | +$1.33M |
|
35
KORU Medical Systems
KRMD
$157M
| $657K | 0.68% |
294,439
-626
| -0.2% | -$1.55K |
|
|
CTHR
36
DELISTED
Charles & Colvard Ltd
CTHR
| $626K | 0.65% |
64,669
+1,241
| +2% | +$15.3K |
|
37
Energy Recovery
ERII
$408M
| $564K | 0.58% |
25,923
-20,422
| -44% | -$460K |
|
38
MGP Ingredients
MGPI
$381M
| $330K | 0.34% |
3,112
-7
| -0.2% | -$752 |
|
|
VNTR
39
DELISTED
Venator Materials PLC
VNTR
| – | – |
-1,110,461
| Closed | -$2.31M |
|
|
VIVO
40
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-214,537
| Closed | -$6.53M |
|
|
HIL
41
DELISTED
Hill International, Inc. Common Stock
HIL
| – | – |
-1,550,372
| Closed | -$2.6M |
|
Similar funds
YCM
PWA
RF
CBOA
WF
SM
TRIA
TW
Meros Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Meros Investment Management held 41 positions worth $97M, down 10% from $108M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Meros Investment Management's Q3 2022 filing shows 6 new, 13 increased, 19 reduced and 3 closed positions. Its largest new stake was i3 Verticals: 111,052 shares worth $2.22M. The largest sale was Meridian Bioscience Inc, an estimated $6.53M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Meros Investment Management's largest Q3 2022 buy was i3 Verticals: 111,052 shares worth $2.22M.
- Meros Investment Management added most to Berry Corp in Q3 2022, an estimated $2.09M increase.
- Meros Investment Management's biggest Q3 2022 reduction was BioLife Solutions, cutting an estimated $1.19M.
- Meros Investment Management fully exited Meridian Bioscience Inc in Q3 2022, selling an estimated $6.53M.
- Meros Investment Management's ten largest holdings make up 44% of its $97M portfolio in Q3 2022.
- Meros Investment Management opened 6 new positions and closed 3 in Q3 2022.
- Meros Investment Management's portfolio value fell 10% quarter-over-quarter to $97M.
Based on Meros Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.